therapeutic

Hoth Therapeutics Shares Spike After Joint Venture for a Potential COVID-19 Vaccine

Hoth Therapeutics Shares Spike After Joint Venture for a Potential COVID-19 Vaccine

Hoth Therapeutics, Inc. (NASDAQ: HOTH) shares spiked about 90% Monday morning after the biopharmaceutical company announced that it has reached an agreement with Voltron Therapeutics, Inc. to form a joint venture entity, to be named HaloVax, which w..

BioXcel Therapeutics Announces Fourth Quarter and Fiscal Year 2019 Earnings

BioXcel Therapeutics Announces Fourth Quarter and Fiscal Year 2019 Earnings

BioXcel Therapeutics, Inc. (NASDAQ: BTAI) reported fourth quarter and full year ended December 31st, 2019 financial results.  BXCL501 is designed for the treatment of acute agitation.  The company initiated phase 3 trials for acute tr..